{
  "risk_score_0_to_1": 0.85,
  "confidence_0_to_1": 0.95,
  "dominant_mechanisms": [
    {"mechanism": "mitochondrial_dysfunction", "score_0_to_1": 0.7},
    {"mechanism": "reactive_metabolite_formation", "score_0_to_1": 0.95},
    {"mechanism": "cholestasis_bsep_inhibition", "score_0_to_1": 0.1},
    {"mechanism": "immune_mediated_injury", "score_0_to_1": 0.4},
    {"mechanism": "oxidative_stress", "score_0_to_1": 0.8}
  ],
  "time_to_onset": "weeks_to_months",
  "dose_dependence": "idiosyncratic",
  "reversibility": "reversible_on_withdrawal",
  "uncertainties": [
    "Exact contribution of hydrazine versus acetylhydrazine to necrosis in humans",
    "Complex interplay between NAT2 acetylator status and CYP2E1 induction levels"
  ],
  "citations": [
    "Metushi, I., et al. (2016). Direct oxidation of isoniazid leads to liver toxicity.",
    "Boelsterli, U. A., & Lee, K. K. (2014). Mechanisms of isoniazid-induced idiosyncratic liver injury."
  ]
}